Loading...

Fidia

BIT:FDA
Snowflake Description

Moderate growth potential with imperfect balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
FDA
BIT
€22M
Market Cap
  1. Home
  2. IT
  3. Capital Goods
Company description

Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells numerical controls and software, milling systems, and after-sales services. The last earnings update was 47 days ago. More info.


Add to Portfolio Compare Print
FDA Share Price and Events
7 Day Returns
0.9%
BIT:FDA
-1.1%
IT Machinery
-2.4%
IT Market
1 Year Returns
-32.9%
BIT:FDA
-20.2%
IT Machinery
-2.5%
IT Market
FDA Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Fidia (FDA) 0.9% 0.5% -13.1% -32.9% -21.6% 37.7%
IT Machinery -1.1% -2.5% -9.4% -20.2% 50.6% 59.8%
IT Market -2.4% 1% -2.2% -2.5% 6.8% -33.9%
1 Year Return vs Industry and Market
  • FDA underperformed the Machinery industry which returned -20.2% over the past year.
  • FDA underperformed the Market in Italy which returned -2.5% over the past year.
Price Volatility
FDA
Industry
5yr Volatility vs Market

FDA Value

 Is Fidia undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Fidia. This is due to cash flow or dividend data being unavailable. The share price is €4.27.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Fidia's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Fidia's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BIT:FDA PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in EUR €-0.27
BIT:FDA Share Price ** BIT (2019-07-19) in EUR €4.27
Italy Machinery Industry PE Ratio Median Figure of 16 Publicly-Listed Machinery Companies 15.89x
Italy Market PE Ratio Median Figure of 240 Publicly-Listed Companies 15.69x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Fidia.

BIT:FDA PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BIT:FDA Share Price ÷ EPS (both in EUR)

= 4.27 ÷ -0.27

-16.05x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Fidia is loss making, we can't compare its value to the IT Machinery industry average.
  • Fidia is loss making, we can't compare the value of its earnings to the Italy market.
Price based on expected Growth
Does Fidia's expected growth come at a high price?
Raw Data
BIT:FDA PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -16.05x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts
113.1%per year
Italy Machinery Industry PEG Ratio Median Figure of 13 Publicly-Listed Machinery Companies 0.79x
Italy Market PEG Ratio Median Figure of 160 Publicly-Listed Companies 1.31x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Fidia, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Fidia's assets?
Raw Data
BIT:FDA PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in EUR €1.60
BIT:FDA Share Price * BIT (2019-07-19) in EUR €4.27
Italy Machinery Industry PB Ratio Median Figure of 22 Publicly-Listed Machinery Companies 1.53x
Italy Market PB Ratio Median Figure of 324 Publicly-Listed Companies 1.49x
BIT:FDA PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BIT:FDA Share Price ÷ Book Value per Share (both in EUR)

= 4.27 ÷ 1.60

2.66x

* Primary Listing of Fidia.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Fidia is overvalued based on assets compared to the IT Machinery industry average.
X
Value checks
We assess Fidia's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Machinery industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Machinery industry average (and greater than 0)? (1 check)
  5. Fidia has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

FDA Future Performance

 How is Fidia expected to perform in the next 1 to 3 years based on estimates from 2 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
113.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Fidia expected to grow at an attractive rate?
  • Fidia's earnings growth is expected to exceed the low risk savings rate of 2.9%.
Growth vs Market Checks
  • Fidia's earnings growth is expected to exceed the Italy market average.
  • Fidia's revenue growth is positive but not above the Italy market average.
Annual Growth Rates Comparison
Raw Data
BIT:FDA Future Growth Rates Data Sources
Data Point Source Value (per year)
BIT:FDA Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 2 Analysts 113.1%
BIT:FDA Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 2 Analysts 2%
Italy Machinery Industry Earnings Growth Rate Market Cap Weighted Average 12.7%
Italy Machinery Industry Revenue Growth Rate Market Cap Weighted Average 5.9%
Italy Market Earnings Growth Rate Market Cap Weighted Average 8.8%
Italy Market Revenue Growth Rate Market Cap Weighted Average 3.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BIT:FDA Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BIT:FDA Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 63 2 2 1
2019-12-31 58 4 2 2
BIT:FDA Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2019-03-31 61 -5 -1
2018-12-31 59 -4 -1
2018-09-30 49 0 -4
2018-06-30 54 3 -3
2018-03-31 47 2 -4
2017-12-31 47 6 -3
2017-09-30 51 2 -1
2017-06-30 50 2 -1
2017-03-31 59 -3 1
2016-12-31 59 -6 2
2016-09-30 58 -2 2
2016-06-30 59 -2 3

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Fidia's earnings are expected to grow significantly at over 20% yearly.
  • Fidia's revenue is expected to grow by 2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BIT:FDA Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below

All data from Fidia Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BIT:FDA Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31 0.39 0.39 0.39 1.00
2019-12-31 0.30 0.30 0.30 1.00
BIT:FDA Past Financials Data
Date (Data in EUR Millions) EPS *
2019-03-31 -0.27
2018-12-31 -0.26
2018-09-30 -0.79
2018-06-30 -0.52
2018-03-31 -0.69
2017-12-31 -0.60
2017-09-30 -0.29
2017-06-30 -0.29
2017-03-31 0.28
2016-12-31 0.48
2016-09-30 0.44
2016-06-30 0.60

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Fidia will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Fidia's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Italy market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Italy market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Fidia has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

FDA Past Performance

  How has Fidia performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Fidia's growth in the last year to its industry (Machinery).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Fidia does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Fidia's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Fidia's 1-year growth to the IT Machinery industry average as it is not currently profitable.
Earnings and Revenue History
Fidia's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Fidia Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BIT:FDA Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 61.26 -1.36 19.23
2018-12-31 58.86 -1.31 19.08
2018-09-30 49.07 -4.05 19.11
2018-06-30 53.81 -2.66 19.00
2018-03-31 47.10 -3.51 19.05
2017-12-31 46.79 -3.07 19.12
2017-09-30 51.43 -1.49 19.52
2017-06-30 49.83 -1.46 19.31
2017-03-31 58.76 1.44 19.22
2016-12-31 59.39 2.46 19.15
2016-09-30 57.57 2.23 19.08
2016-06-30 58.70 3.08 19.02
2016-03-31 62.57 3.85 18.78
2015-12-31 61.09 2.72 18.90
2015-09-30 62.64 4.93 18.35
2015-06-30 64.96 5.18 17.92
2015-03-31 54.79 2.34 17.75
2014-12-31 55.00 2.89 17.01
2014-09-30 48.55 0.22 16.60
2014-06-30 43.53 -0.93 16.67
2014-03-31 47.79 -0.43 16.78
2013-12-31 44.97 -1.44 16.96
2013-09-30 46.49 -1.97 17.13
2013-06-30 49.61 -1.49 17.27
2013-03-31 42.04 -2.26 17.09
2012-12-31 47.28 -0.05 17.00
2012-09-30 44.56 -0.08 16.74

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Fidia has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Fidia has efficiently used its assets last year compared to the IT Machinery industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Fidia improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Fidia's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Machinery industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Fidia has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

FDA Health

 How is Fidia's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Fidia's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Fidia is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Fidia's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Fidia's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 2.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Fidia Company Filings, last reported 3 months ago.

BIT:FDA Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 9.79 17.97 3.16
2018-12-31 11.96 12.45 6.56
2018-09-30 9.03 18.04 5.43
2018-06-30 11.11 12.23 8.83
2018-03-31 10.79 17.29 8.55
2017-12-31 13.32 17.69 11.52
2017-09-30 13.42 18.43 7.45
2017-06-30 14.17 13.38 9.64
2017-03-31 15.81 17.73 10.14
2016-12-31 18.94 16.34 8.93
2016-09-30 16.70 16.79 9.29
2016-06-30 17.66 11.28 8.06
2016-03-31 15.52 11.00 11.48
2015-12-31 19.03 9.58 16.04
2015-09-30 17.32 9.59 11.16
2015-06-30 17.07 7.96 12.68
2015-03-31 14.33 5.25 5.72
2014-12-31 16.51 6.20 10.72
2014-09-30 12.52 8.00 7.64
2014-06-30 11.15 7.39 7.50
2014-03-31 11.09 7.90 7.18
2013-12-31 12.85 6.32 8.51
2013-09-30 11.86 7.33 10.54
2013-06-30 12.74 10.65 13.02
2013-03-31 12.46 10.92 9.25
2012-12-31 14.84 9.73 10.40
2012-09-30 14.21 7.54 11.11
  • Fidia's level of debt (183.6%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (71.3% vs 183.6% today).
  • Operating cash flow is negative therefore debt is not well covered.
  • Unable to confirm if the interest payments on Fidia's debt are well covered by earnings due to lack of past financial data.
X
Financial health checks
We assess Fidia's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Fidia has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

FDA Dividends

 What is Fidia's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Fidia dividends. Estimated to be 1.48% next year.
If you bought €2,000 of Fidia shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Fidia's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Fidia's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BIT:FDA Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 2 Analyst Estimates (S&P Global) See Below
Italy Machinery Industry Average Dividend Yield Market Cap Weighted Average of 11 Stocks 2.1%
Italy Market Average Dividend Yield Market Cap Weighted Average of 185 Stocks 4.1%
Italy Minimum Threshold Dividend Yield 10th Percentile 1%
Italy Bottom 25% Dividend Yield 25th Percentile 2.1%
Italy Top 25% Dividend Yield 75th Percentile 4.5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BIT:FDA Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2020-12-31 0.04 1.00
2019-12-31 0.08 2.00
BIT:FDA Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2019-06-03 0.000 0.000
2019-04-23 0.000 0.000
2017-03-15 0.200 2.928
2016-03-30 0.400 6.898
2016-03-14 0.400 6.256
2015-03-30 0.250 3.767
2015-03-13 0.250 4.273

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Fidia has not reported any payouts.
  • Unable to verify if Fidia's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Fidia's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Fidia has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Fidia's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Fidia afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Fidia has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

FDA Management

 What is the CEO of Fidia's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Giuseppe Morfino
COMPENSATION €372,000
AGE 75
TENURE AS CEO 2.3 years
CEO Bio

Engineer Giuseppe Morfino has been the Chairman & CEO of Fidia SpA since February 14, 2006 and has been its General Manager since July 14, 2017. Engineer Morfino serves as the President and of Fidia Spa and served as its Chief Executive Officer since 2008. He serves as the President and Managing Director at Fidia Spa. He serves as the President of Shenyang Fidia NC & Machine Co. Ltd. He serves as a Managing Director (Chairman) of Fidia Sp. Z o.o. He served as Managing Director of Geschäftsfürer of Fidia GmbH of Fidia Spa. From 1969 to 1971, he contributed to the development of software projects for applications on measuring machines at the DEA S.p.A. of Moncalieri (province of Turin). From 1971 to 1972, he was involved in the development of research into Systems Theory at the Istituto di Automatica Informatica of Turin Polytechnic. From 1972 to 1973, he worked as a Consultant for software projects, collaborating in particular with the Information Systems Management of Fiat S.p.A. He serves as the Chairman of Fidia Co. and Fidia S.a.r.l. He serves as the Chairman of the Board of Directors of Beijing Fidia Machinery & Electronics Co. Ltd. He serves as a Sole Director of Fidia Iberica S.A. and Windco Srl. He serves as a Director of CSEA (Consortium for the development of Eletronics and Automation). He has been a Director of Fidia SpA since April 29, 2002. He served as an Independent Director of Prima Industrie SpA from May 11, 2001 to June 7, 2005. Mr. Morfino graduated from Turin Polytechnic in Electrotechnical Engineering in 1970.

CEO Compensation
  • Giuseppe's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Giuseppe's remuneration is higher than average for companies of similar size in Italy.
Management Team

Giuseppe Morfino

TITLE
Chairman
COMPENSATION
€372K
AGE
75
TENURE
2.3 yrs

Carlos Maidagan Aguirre

TITLE
Deputy Chairman of the Board
COMPENSATION
€185K
AGE
58

Luigino Azzolin

TITLE
Director of Financial Reporting & Director
COMPENSATION
€18K
AGE
77

Massimiliano Pagnone

TITLE
Group CFO

Fabio Venturi

TITLE
Executive Officer of Technical Assistance & After Sales Service and Member of the Management Board

Guido Furxhi

TITLE
Executive Officer of High Speed Milling Department

Luigi Visconti

TITLE
General Manager
COMPENSATION
€130K
AGE
70
TENURE
24.5 yrs
Board of Directors Tenure

Average tenure and age of the Fidia board of directors in years:

2.3
Average Tenure
56.5
Average Age
  • The average tenure for the Fidia board of directors is less than 3 years, this suggests a new board.
Board of Directors

Giuseppe Morfino

TITLE
Chairman
COMPENSATION
€372K
AGE
75
TENURE
2.3 yrs

Carlos Maidagan Aguirre

TITLE
Deputy Chairman of the Board
COMPENSATION
€185K
AGE
58
TENURE
2.3 yrs

Luigino Azzolin

TITLE
Director of Financial Reporting & Director
COMPENSATION
€18K
AGE
77
TENURE
2.3 yrs

Maurizio Ferrero

TITLE
Chairman of the Board of Statutory Auditors
COMPENSATION
€8K
AGE
55
TENURE
2.3 yrs

Guido Giovando

TITLE
Director
COMPENSATION
€12K
AGE
48
TENURE
2.3 yrs

Anna Ferrero

TITLE
Independent Director
COMPENSATION
€12K
AGE
67
TENURE
2.3 yrs

Paola Savarino

TITLE
Independent Director
TENURE
2.3 yrs

Laura Morgagni

TITLE
Independent Director
AGE
55
TENURE
2.3 yrs

Marcello Rabbia

TITLE
Statutory Auditor
TENURE
2.3 yrs

Chiara Siccardi

TITLE
Statutory Auditor
AGE
43
TENURE
0.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
28. Jan 19 Sell Giuseppe Morfino Individual 15. Jan 19 23. Jan 19 -100,240 €5.66 €-566,741
25. Jan 19 Sell Giuseppe Morfino Individual 15. Jan 19 16. Jan 19 -49,760 €5.12 €-249,229
03. Aug 18 Sell Giuseppe Morfino Individual 31. Jul 18 31. Jul 18 -50,000 €6.81 €-340,600
X
Management checks
We assess Fidia's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Fidia has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

FDA News

Simply Wall St News

How Much Of Fidia S.p.A. (BIT:FDA) Do Insiders Own?

As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.' Fidia is not a large company by global standards. … View our latest analysis for Fidia BIT:FDA Ownership Summary, July 3rd 2019 What Does The Lack Of Institutional Ownership Tell Us About Fidia? … Insider Ownership Of Fidia The definition of an insider can differ slightly between different countries, but members of the board of directors always count.

Simply Wall St -

The Fidia (BIT:FDA) Share Price Has Gained 63% And Shareholders Are Hoping For More

Check out our latest analysis for Fidia Given that Fidia didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. … A Dividend Lost It's important to keep in mind that we've been talking about the share price returns, which don't include dividends, while the total shareholder return does. … Over the last 5 years, Fidia generated a TSR of 83%, which is, of course, better than the share price return.

Simply Wall St -

Update: Fidia (BIT:FDA) Stock Gained 49% In The Last Five Years

Fidia isn't a profitable company, so it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). … When a company doesn't make profits, we'd generally expect to see good revenue growth. … In the last 5 years Fidia saw its revenue grow at 1.0% per year.

Simply Wall St -

Does The Fidia S.p.A. (BIT:FDA) Share Price Tend To Follow The Market?

(BIT:FDA), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. … Some investors use beta as a measure of how much a certain stock is impacted by market risk (volatility). … A stock with a beta greater than one is more sensitive to broader market movements than a stock with a beta of less than one.

Simply Wall St -

How Many Insiders Sold Fidia S.p.A. (BIT:FDA) Shares?

So we'll take a look at whether insiders have been buying or selling shares in Fidia S.p.A. … Over the last year, we can see that the biggest insider sale was by Chairman Giuseppe Morfino for €341k worth of shares, at about €6.81 per share … Although we don't gain confidence from insider selling, we note that this large sale was at well above current price of €5.34

Simply Wall St -

Do Insiders Own Shares In Fidia S.p.A. (BIT:FDA)?

Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. … As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.'. … Let's take a closer look to see what the different types of shareholder can tell us about FDA

Simply Wall St -

Investors In Fidia SpA (BIT:FDA) Should Consider This Data

A large part of investment returns can be generated by dividend-paying stock given their role in compounding returns over time. … Fidia SpA (BIT:FDA) has recently paid dividends to shareholders, and currently yields 3.7%. … Let's dig deeper into whether Fidia should have a place in your portfolio.

Simply Wall St -

Who Are The Top Investors In Fidia SpA (BIT:FDA)?

Today, I will be analyzing Fidia SpA’s (BIT:FDA) recent ownership structure, an important but not-so-popular subject among individual investors. … When it comes to ownership structure of a company, the impact has been observed in both the long-and short-term performance of shares. … The implications of these institutions’ actions can either benefit or hinder individual investors, so it is important to understand the ownership composition of your stock investment.

Simply Wall St -

Estimating The Intrinsic Value Of Fidia SpA (BIT:FDA)

by projecting its future cash flows and then discounting them to today's value. … discounted cash flows (DCF). … If you want to learn more about discounted cash flow, the basis for my calcs can be read in detail in the Simply Wall St analysis model

Simply Wall St -

Why You Should Not Buy Fidia SpA (BIT:FDA) For Dividend

In the past 3 years Fidia SpA (BIT:FDA) has returned an average of 5.00% per year to investors in the form of dividend payouts. … Here's how I find good dividend stocks … When assessing a stock as a potential addition to my dividend Portfolio, I look at these five areas:

Simply Wall St -

FDA Company Info

Description

Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells numerical controls and software, milling systems, and after-sales services. It offers HSM machines and milling heads. The company also provides accessories, including HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC device to measure length and diameter of the tool, as well as check the shape; K5 tracer to perform continuous scanning of 3D surfaces; pushbutton panels; and XPower digital drives and I/O Line modules. In addition, it offers software products, such as ViMill, an anti-collision solution; HiMonitor, a software to monitor activities of the machine; Velocity 5, a solution for axes control to enhance the performances of the machine; HiMill, a computer aided manufacturing (CAM) software for the machining of dies, models, and aeronautical components; and Isograph, a CAD/CAM product for on board programming, as well as provides procedure-PRX advanced programming that simplifies repetitive machining operations, enhances operating safety, and enables a series of unmanned machining operations to be performed. The company serves automotive, aerospace, and energy industries in Europe, Asia, North and South America, and internationally. Fidia S.p.A. was founded in 1974 and is headquartered in San Mauro Torinese, Italy.

Details
Name: Fidia S.p.A.
FDA
Exchange: BIT
Founded: 1974
€21,934,770
5,113,000
Website: http://www.fidia.it
Address: Fidia S.p.A.
Corso Lombardia, 11,
San Mauro Torinese,
Turin, 10099,
Italy
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BIT FDA Common Stock Borsa Italiana IT EUR 28. Nov 2000
BATS-CHIXE FDAM Common Stock BATS 'Chi-X Europe' GB EUR 28. Nov 2000
Number of employees
Current staff
Staff numbers
336
Fidia employees.
Industry
Industrial Machinery
Capital Goods
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/20 20:48
End of day share price update: 2019/07/19 00:00
Last estimates confirmation: 2019/04/19
Last earnings filing: 2019/06/03
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.